In this study, MS-lincRNA BCLIN25, which serves as a HER2 subtype-specific lincRNA, was found to contribute to tumorigenesis by upregulating ERBB2 expression via epigenetic modification and RNA–RNA interactions in breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.